MDPI and ACS Style
Kumar, D.; Aggarwal, N.; Kumar, H.; Kapoor, G.; Deep, A.; Bibi, S.; Sharma, A.; Chopra, H.; Kumar Marwaha, R.; Alshammari, A.;
et al. 2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential. Pharmaceuticals 2023, 16, 805.
https://doi.org/10.3390/ph16060805
AMA Style
Kumar D, Aggarwal N, Kumar H, Kapoor G, Deep A, Bibi S, Sharma A, Chopra H, Kumar Marwaha R, Alshammari A,
et al. 2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential. Pharmaceuticals. 2023; 16(6):805.
https://doi.org/10.3390/ph16060805
Chicago/Turabian Style
Kumar, Davinder, Navidha Aggarwal, Harsh Kumar, Garima Kapoor, Aakash Deep, Shabana Bibi, Aastha Sharma, Hitesh Chopra, Rakesh Kumar Marwaha, Abdulrahman Alshammari,
and et al. 2023. "2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential" Pharmaceuticals 16, no. 6: 805.
https://doi.org/10.3390/ph16060805